Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model

Neuroscience Letters

Volumn 315, Issue 3, 2001, Pages 149-153

  Schilling, Gabriele ^a,b   Coonfield, Michael L ^a   Ross, Christopher A ^a   Borchelt, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 720 Rutland Avenue ^*  (United States)

Author keywords

Coenzyme Q10; Drug trial; HD N171 82Q transgenic mice; Huntington's disease; Intranuclear inclusions; Remacemide hydrochloride

Indexed keywords

REMACEMIDE; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DOSE TIME EFFECT RELATION; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TRANSGENIC MOUSE;

ACETAMIDES; ANIMALS; ANTIOXIDANTS; DRUG THERAPY, COMBINATION; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; SURVIVAL ANALYSIS; TIME FACTORS; UBIQUINONE;

EID: 0035960544     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)02326-6     Document Type: Article

References (18)

1. Mitochondrial dysfunction in neurodegenerative diseases
2. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
3. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
4. Kainic acid and 4-aminopyridine seizure models in mice: Evaluation of efficacy of anti-epileptic agents and calcium antagonists
5. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
6. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
7. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
8. Mitochondrial defect in Huntington's disease caudate nucleus
9. A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes
10. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease
11. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects
12. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
13. Glutamine repeats as polar zippers: Their role in inherited neurodegenerative disease
14. Huntington's disease and dentatorubral-pallidoluysian atrophy: Proteins, pathogenesis and pathology
15. Polyglutamine expanded Huntingtin promotes sensitization of NMDA receptors via post synaptic associated protein 95
16. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
17. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
18. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse